207 related articles for article (PubMed ID: 21252475)
1. Early detection of preeclampsia using inhibin a and other second-trimester serum markers.
Ree PH; Hahn WB; Chang SW; Jung SH; Kang JH; Cha DH; Kang MS; Huh JY
Fetal Diagn Ther; 2011; 29(4):280-6. PubMed ID: 21252475
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
3. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia.
Olsen RN; Woelkers D; Dunsmoor-Su R; Lacoursiere DY
Am J Obstet Gynecol; 2012 Sep; 207(3):228.e1-7. PubMed ID: 22818876
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
[TBL] [Abstract][Full Text] [Related]
5. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
6. Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
[TBL] [Abstract][Full Text] [Related]
7. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
8. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
9. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia.
Aquilina J; Maplethorpe R; Ellis P; Harrington K
Placenta; 2000; 21(5-6):487-92. PubMed ID: 10940198
[TBL] [Abstract][Full Text] [Related]
10. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy.
Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293
[TBL] [Abstract][Full Text] [Related]
11. Screening in early pregnancy for pre-eclampsia using Down syndrome quadruple test markers.
Wald NJ; Morris JK; Ibison J; Wu T; George LM
Prenat Diagn; 2006 Jun; 26(6):559-64. PubMed ID: 16700087
[TBL] [Abstract][Full Text] [Related]
12. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
13. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
[TBL] [Abstract][Full Text] [Related]
14. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome.
Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ
J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623
[TBL] [Abstract][Full Text] [Related]
15. Mid-trimester triple test levels in early and late onset severe pre-eclampsia.
Shenhav S; Gemer O; Sassoon E; Volodarsky M; Peled R; Segal S
Prenat Diagn; 2002 Jul; 22(7):579-82. PubMed ID: 12124692
[TBL] [Abstract][Full Text] [Related]
16. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
17. Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance.
Rudnicka AR; Wald NJ; Huttly W; Hackshaw AK
Prenat Diagn; 2002 Oct; 22(10):893-7. PubMed ID: 12378572
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancy.
Lambert-Messerlian GM; Silver HM; Petraglia F; Luisi S; Pezzani I; Maybruck WM; Hogge WA; Hanley-Yanez K; Roberts JM; Neveux LM; Canick JA
J Soc Gynecol Investig; 2000; 7(3):170-4. PubMed ID: 10865185
[TBL] [Abstract][Full Text] [Related]
20. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]